Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001236368-12-000002
Filing Date
2012-08-21
Accepted
2012-08-21 17:55:41
Documents
1
Period of Report
2012-08-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 20662
  Complete submission text file 0001236368-12-000002.txt   21990
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O TRANSKARYOTIC THERAPIES INC 700 MAIN STREET CAMBRIDGE MA 02139
Business Address
GILBERT WALTER PHD (Reporting) CIK: 0001236368 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 121048530